Charlotte Andersson1,2, Thomas Gerds3, Emil Fosbøl4, Matthew Phelps5, Julie Andersen5, Morten Lamberts2, Anders Holt2, Jawad H Butt4, Christian Madelaire2, Gunnar Gislason4,5, Christian Torp-Pedersen6,7, Lars Køber4, Morten Schou2. 1. Department of Medicine, Section of Cardiovascular Medicine, Boston Medical Center, Boston University, MA (C.A.). 2. Department of Cardiology, Herlev and Gentofte Hospital, Denmark (C.A., M.L., A.H., C.M., G.G., M.S.). 3. Department of Biostatistics, Copenhagen University, Denmark (T.G.). 4. Heart Center, Rigshospitalet, Copenhagen, Denmark (E.F., J.H.B., G.G., L.K.). 5. Danish Heart Foundation, Section of Cardiovascular Research, Copenhagen, Denmark (M.P., J.A., G.G.). 6. Department of Cardiology, Nordsjællands Hospital, Hillerød, Denmark (C.T.-P.). 7. Department of Cardiology, Aalborg University Hospital, Denmark (C.T.-P.).
Abstract
BACKGROUND: The Danish government ordered a public lockdown on March 12, 2020, because of the coronavirus disease 2019 (COVID-19) pandemic. We investigated the immediate consequences of such a lockdown for patients with heart failure (HF). METHODS: Using the Danish nationwide administrative databases, we investigated the incidence of new-onset HF and hospitalizations for worsening HF before and after the lockdown (January 1 to March 11 versus March 12 to March 31) in 2020 versus 2019. We also investigated the mortality for all patients with HF and in COVID-19-infected patients with HF. RESULTS: Rates of new-onset HF between January 1 and March 11 were comparable for 2020 and 2019 (1.83 versus 1.78 per 10 000 person-years; P=0.19), while hospitalizations for worsening HF were slightly higher in 2020 versus 2019 (1.04 versus 0.93 per 1000 person-years; P=0.02). In the lockdown period, rates of new-onset HF diagnoses (1.26 versus 2.25 per 1000 person-years) and of hospitalizations for worsening HF (0.63 versus 0.99 per 1000 person-years) were significantly lower in 2020 versus 2019 (P for both, <0.0001). Mortality was similar before and after the national lockdown for the population with HF. We observed 90 HF patients with diagnosed COVID-19 infection, of whom 37% (95% CI, 23%-50%) died within 15 days. CONCLUSIONS: The number of patients hospitalized with worsening HF or diagnosed with new-onset HF was markedly reduced after lockdown but has not yet impacted mortality in HF patients at a population-based level. However, these data raise concerns for a potential undertreatment of HF currently that may impact prognosis in the longer term.
BACKGROUND: The Danish government ordered a public lockdown on March 12, 2020, because of the coronavirus disease 2019 (COVID-19) pandemic. We investigated the immediate consequences of such a lockdown for patients with heart failure (HF). METHODS: Using the Danish nationwide administrative databases, we investigated the incidence of new-onset HF and hospitalizations for worsening HF before and after the lockdown (January 1 to March 11 versus March 12 to March 31) in 2020 versus 2019. We also investigated the mortality for all patients with HF and in COVID-19-infectedpatients with HF. RESULTS: Rates of new-onset HF between January 1 and March 11 were comparable for 2020 and 2019 (1.83 versus 1.78 per 10 000 person-years; P=0.19), while hospitalizations for worsening HF were slightly higher in 2020 versus 2019 (1.04 versus 0.93 per 1000 person-years; P=0.02). In the lockdown period, rates of new-onset HF diagnoses (1.26 versus 2.25 per 1000 person-years) and of hospitalizations for worsening HF (0.63 versus 0.99 per 1000 person-years) were significantly lower in 2020 versus 2019 (P for both, <0.0001). Mortality was similar before and after the national lockdown for the population with HF. We observed 90 HF patients with diagnosed COVID-19infection, of whom 37% (95% CI, 23%-50%) died within 15 days. CONCLUSIONS: The number of patients hospitalized with worsening HF or diagnosed with new-onset HF was markedly reduced after lockdown but has not yet impacted mortality in HF patients at a population-based level. However, these data raise concerns for a potential undertreatment of HF currently that may impact prognosis in the longer term.
Authors: Vincent Issac Lau; Sumeet Dhanoa; Harleen Cheema; Kimberley Lewis; Patrick Geeraert; David Lu; Benjamin Merrick; Aaron Vander Leek; Meghan Sebastianski; Brittany Kula; Dipayan Chaudhuri; Arnav Agarwal; Daniel J Niven; Kirsten M Fiest; Henry T Stelfox; Danny J Zuege; Oleksa G Rewa; Sean M Bagshaw Journal: PLoS One Date: 2022-06-24 Impact factor: 3.752
Authors: Sebastian König; Laura Ueberham; Vincent Pellissier; Sven Hohenstein; Andreas Meier-Hellmann; Holger Thiele; Vusal Ahmadli; Michael A Borger; Ralf Kuhlen; Gerhard Hindricks; Andreas Bollmann Journal: Clin Cardiol Date: 2021-01-26 Impact factor: 3.287
Authors: Neal Yuan; Patrick G Botting; Yaron Elad; Shaun J Miller; Susan Cheng; Joseph E Ebinger; Michelle M Kittleson Journal: Circ Heart Fail Date: 2021-09-30 Impact factor: 10.447
Authors: Sheila M Manemann; Yariv Gerber; Suzette J Bielinski; Alanna M Chamberlain; Karen L Margolis; Susan A Weston; Jill M Killian; Véronique L Roger Journal: BMC Public Health Date: 2021-06-01 Impact factor: 3.295
Authors: Matthew Phelps; Daniel Mølager Christensen; Thomas Gerds; Emil Fosbøl; Christian Torp-Pedersen; Morten Schou; Lars Køber; Kristian Kragholm; Charlotte Andersson; Tor Biering-Sørensen; Helle Collatz Christensen; Mikkel Porsborg Andersen; Gunnar Gislason Journal: Eur Heart J Qual Care Clin Outcomes Date: 2021-03-15
Authors: Jesus Alvarez-Garcia; Samuel Lee; Arjun Gupta; Matthew Cagliostro; Aditya A Joshi; Mercedes Rivas-Lasarte; Johanna Contreras; Sumeet S Mitter; Gina LaRocca; Pilar Tlachi; Danielle Brunjes; Benjamin S Glicksberg; Matthew A Levin; Girish Nadkarni; Zahi Fayad; Valentin Fuster; Donna Mancini; Anuradha Lala Journal: J Am Coll Cardiol Date: 2020-10-28 Impact factor: 24.094
Authors: Elisabeth Helen Anna Mills; Amalie Lykkemark Møller; Filip Gnesin; Nertila Zylyftari; Marcella Broccia; Britta Jensen; Morten Schou; Emil L Fosbøl; Lars Køber; Mikkel Porsborg Andersen; Matthew Phelps; Thomas Gerds; Christian Torp-Pedersen Journal: Eur J Epidemiol Date: 2020-09-21 Impact factor: 8.082
Authors: Antonio Cannatà; Daniel I Bromage; Irfan A Rind; Caterina Gregorio; Clare Bannister; Mohammed Albarjas; Susan Piper; Ajay M Shah; Theresa A McDonagh Journal: Eur J Heart Fail Date: 2020-09-28 Impact factor: 17.349